Form 4 for MRK Merck & Co.
Accepted 2026-08-07 16:21:19 ET · period of report 2026-08-05 · accession 0000310158-26-000215 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-08-07 16:21 | 2026-08-05 | MRK | Maraldo David R. | EVP, Pres. MMD | M - OptEx | $82.25 | +18.7K | 20.9K | +853% | +$1.54M |
| DM | 2026-08-07 16:21 | 2026-08-05 | MRK | Maraldo David R. | EVP, Pres. MMD | S - Sale+OE | $128.72 | -18.7K | 18.2K | -51% | -$2.41M |
| DM | 2026-08-07 16:21 | 2026-08-05 | MRK | Maraldo David R. | EVP, Pres. MMD | M - OptEx | $0.00 | -18.7K | 5,374 | -78% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-05 | M | A | 6,311 | $73.73 | 24,523.43 | D | — | — | |
| 2 | Common | Common Stock | 2026-08-05 | S | D | 6,311 | $128.72 | 18,212.43 | D | — | — | (F1) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.6400 to $128.8500, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in the footnote. |
| 3 | Common | Common Stock | 2026-08-05 | M | A | 9,709 | $87.10 | 27,921.43 | D | — | — | |
| 4 | Common | Common Stock | 2026-08-05 | S | D | 9,709 | $128.72 | 18,212.43 | D | — | — | (F1) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.6400 to $128.8500, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in the footnote. |
| 5 | Common | Common Stock | 2026-08-05 | M | A | 2,686 | $84.71 | 20,898.43 | D | — | — | |
| 6 | Common | Common Stock | 2026-08-05 | S | D | 2,686 | $128.72 | 18,212.43 | D | — | — | (F1) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.6400 to $128.8500, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in the footnote. |
| 7 | Derivative | Stock Option (Right to Buy) | 2026-08-05 | M | D | 6,311 | $0.00 | 3,154 | D | $73.73 · 2022-05-04 to 2031-05-03 | 6,311 Common Stock | (F2) The option vested and became exercisable in three equal installments on 5/4/2022, 5/4/2023, and 5/4/2024. |
| 8 | Derivative | Stock Option (Right to Buy) | 2026-08-05 | M | D | 9,709 | $0.00 | 0 | D | $87.10 · 2023-05-03 to 2032-05-02 | 9,709 Common Stock | (F3) The option vested and become exercisable in three equal installments on 5/3/2023, 5/3/2024, and 5/3/2025. |
| 9 | Derivative | Stock Option (Right to Buy) | 2026-08-05 | M | D | 2,686 | $0.00 | 5,374 | D | $84.71 · 2026-04-29 to 2035-04-28 | 2,686 Common Stock | (F4) The options vest and become exercisable in three equal installments on 4/29/2026, 4/29/2027, and 4/29/2028. |